Quarterly Spotlight - Corporate Venture Capital Deal Analysis - Q2'2024

In Q2 2024, deal activity by corporate venture capital funds decreased. However, CVC funds strategically increased their ticket sizes to support their parent companies' global strategies.

In Q2 2024, corporate venture capital (CVC) funds dropped in deal activity. However, CVC funds strategically increased their ticket sizes to support their parent companies' global strategies. Deal activity decreased 9% compared to the previous quarter, whereas capital investments remained stable at $25 billion. North American and Asian funds accounted for 77% of total capital investments, focusing on software, biotech, and pharma startups, which attracted 58% of total investments—a 26% rise from Q1 2024.

Leading companies such as OKX, Sumitomo Mitsui, Alphabet, and Coinbase spearheaded deal activity, completing around 85 deals in the quarter. Reflecting their parent companies' strategies, CVCs emphasized building corporate technology capabilities.

This second edition of the Quarterly Insights on CVC Deal Analysis provides an overview of global CVC investment activity, highlighting key sectors, active CVC funds, and significant deals completed during the quarter.